A report from the American Cancer Society Cancer Action Network and Georgetown University Center on Health Insurance Reforms shows that while opportunities for coverage have improved, cancer patients struggle with financial challenges in affording their treatment, despite reductions in out-of-pocket costs and patient protections under current law.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
